Gene · 57126
Papers3,864
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,864
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Development and validation of a novel criterion of histologic healing in ulcerative colitis defined by inflammatory cell enumeration in lamina propria mucosa: A multicenter retrospective cohort in China. | Chin Med J (Engl) | 2024 | 38738696 | PubTator, text mining | PubMed |
| Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction. | Front Immunol | 2024 | 38715615 | PubTator, text mining | PubMed |
| CD177 drives the transendothelial migration of Treg cells enriched in human colorectal cancer. | Clin Transl Immunology | 2024 | 38596253 | PubTator, text mining | PubMed |
| Predictive Value of a Diagnostic Five-Gene Biomarker for Pediatric Sepsis. | J Inflamm Res | 2024 | 38595339 | PubTator, text mining | PubMed |
| Side scatter ratio of the CD105-positive and CD105-negative red blood cell fractions is useful for the detection of low-grade myelodysplastic neoplasms by flow cytometry. | Am J Clin Pathol | 2024 | 38581145 | PubTator, text mining | PubMed |
| Peripheral priming induces plastic transcriptomic and proteomic responses in circulating neutrophils required for pathogen containment. | Sci Adv | 2024 | 38517968 | PubTator, text mining | PubMed |
| Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma. | Oncoimmunology | 2024 | 38516269 | PubTator, text mining | PubMed |
| Prognostic value of tumor‑associated CD177+ neutrophils in lung adenocarcinoma. | Oncol Lett | 2024 | 38495836 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Exploration and Preliminary Clinical Verification for the Identification of Crucial Biomarkers in Severe Cases of COVID-19. | J Inflamm Res | 2024 | 38495341 | PubTator, text mining | PubMed |
| The CD177 c.1291A Allele Leads to a Loss of Membrane Expression and Mimics a CD177-Null Phenotype. | Int J Mol Sci | 2024 | 38474126 | PubTator, text mining | PubMed |
| Targeted Degradation of Cell-Surface Proteins via Chaperone-Mediated Autophagy by Using Peptide-Conjugated Antibodies. | Angew Chem Int Ed Engl | 2024 | 38472118 | PubTator, text mining | PubMed |
| Deciphering the Synthetic and Refolding Strategy of a Cysteine-Rich Domain in the Tumor Necrosis Factor Receptor (TNF-R) for Racemic Crystallography Analysis and d-Peptide Ligand Discovery. | ACS Bio Med Chem Au | 2024 | 38404743 | PubTator, text mining | PubMed |
| Fc receptors are key discriminatory markers of granulocytes subsets in people living with HIV-1. | Front Immunol | 2024 | 38384451 | PubTator, text mining | PubMed |
| High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer. | BMC Cancer | 2024 | 38308214 | PubTator, text mining | PubMed |
| Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects. | PLoS One | 2024 | 38306344 | PubTator, text mining | PubMed |
| Predicting colorectal cancer prognosis based on long noncoding RNAs of disulfidptosis genes. | World J Clin Oncol | 2024 | 38292658 | PubTator, text mining | PubMed |
| Identification of miRNA, lncRNA and circRNA associated with gastric cancer metabolism through sequencing and bioinformatics analysis. | Pathol Res Pract | 2024 | 38290402 | PubTator, text mining | PubMed |
| Bacteria-Based Nanoprobes for Cancer Therapy. | Int J Nanomedicine | 2024 | 38283198 | PubTator, text mining | PubMed |
| The Expanding Scope of Alpha 1 Antitrypsin Deficiency. | Mayo Clin Proc Innov Qual Outcomes | 2024 | 38283099 | PubTator, text mining | PubMed |
| HIF‑1 and macrophage activation signalling pathways are potential biomarkers of invasive aspergillosis. | Exp Ther Med | 2024 | 38274338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57126/papers?page=8